Current Problems in Cardiology
Volume 33, Issue 8 , Pages 417-457 , August 2008

Percutaneous Valve Procedures: An Update

References 

  1. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230–268
  2. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84–e231
  3. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231–1243
  4. Vassiliades TA, Block PC, Cohn LH, et al. The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA). J Am Coll Cardiol. 2005;45:1554–1560
  5. Farhat MB, Ayari M, Maatouk F, et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial. Circulation. 1998;97:245–250
  6. Feldman T. Core curriculum for interventional cardiology: percutaneous valvuloplasty. Catheter Cardiovasc Interv. 2003;60:48–56
  7. Pate GE, Al Zubaidi A, Chandavimol M, et al. Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv. 2006;68:528–533
  8. Alfieri O, De Bonis M, Lapenna E, et al. “Edge-to-edge” repair for anterior mitral leaflet prolapse. Semin Thorac Cardiovasc Surg. 2004;16:182–187
  9. St Goar FG, Fann JI, Komtebedde J, et al. Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model. Circulation. 2003;108:1990–1993
  10. Naqvi TZ, Buchbinder M, Zarbatany D, et al. Beating-heart percutaneous mitral valve repair using a transcatheter endovascular suturing device in an animal model. Catheter Cardiovasc Interv. 2007;69:525–531
  11. Webb JG, Harnek J, Munt BI, et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation. 2006;113:851–855
  12. Liddicoat JR, Mac Neill BD, Gillinov AM, et al. Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv. 2003;60:410–416
  13. Maniu CV, Patel JB, Reuter DG, et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol. 2004;44:1652–1661
  14. Fukamachi K, Inoue M, Popovic ZB, et al. Off-pump mitral valve repair using the Coapsys device: a pilot study in a pacing-induced mitral regurgitation model. Ann Thorac Surg. 2004;77:688–692
  15. Mishra YK, Mittal S, Jaguri P, et al. Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. Ann Thorac Surg. 2006;81:42–46
  16. Pedersen WR, Block P, Feldman T. The iCoapsys Repair System for the percutaneous treatment of functional mitral insufficiency. EuroIntervention. 2007;1:A44–A48
  17. Rogers JH, Macoviak JA, Rahdert DA, et al. Percutaneous septal sinus shortening: a novel procedure for the treatment of functional mitral regurgitation. Circulation. 2006;113:2329–2334
  18. Palacios IF, Condado JA, Brandi S, et al. Safety and feasibility of acute percutaneous septal sinus shortening: first-in-human experience. Catheter Cardiovasc Interv. 2007;69:513–518
  19. Cribier A, Savin T, Saoudi N, et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement?. Lancet. 1986;1:63–67
  20. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty (Insights into prognosis of valvular aortic stenosis). Circulation. 1994;89:642–650
  21. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves (Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs). Eur Heart J. 1992;13:704–708
  22. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–3008
  23. Webb JG, Pasupati S, Achtem L, et al. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheter Cardiovasc Interv. 2006;68:199–204
  24. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698–703
  25. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842–850
  26. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755–763
  27. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114:591–596
  28. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation. 2006;114:1616–1624
  29. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76
  30. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005;46:2134–2140
  31. Rinaldi M, Kar S, Hermiller J, et al. Significant reverse remodeling of the left ventricle one year after percutaneous mitral repair with the MitraClip device. Am J Cardiol. 2007;100:S56–S59(Abstr)
  32. Webb JG, Kuck KH, Stone G, et al. Percutaneous mitral annuloplasty with the MONARC system: Preliminary results from the EVOLUTION trial. Am J Cardiol. 2006;98:49M
  33. Dubreuil O, Basmadjian A, Ducharme A, et al. Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: first in man experience with a temporary implant. Catheter Cardiovasc Interv. 2007;69:1053–1061
  34. Kaye DM, Byrne M, Alferness C, et al. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation. 2003;108:1795–1797
  35. Grossi EA, Saunders PC, Woo YJ, et al. Intraoperative effects of the coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Ann Thorac Surg. 2005;80:1706–1711
  36. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214–1223
  37. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation. 2007;116:I240–I245
  38. Kodali S, O'Neill W, Moses J, et al. Six month to one year clinical outcomes following retrograde percutaneous aortic valve replacement in high risk patients: a report from the REVIVAL-II trial. Am J Cardiol. 2007;100:S56–S59(Abstr)
  39. Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv. 2005;66:465–469
  40. Walther T, Falk V, Dewey T, et al. Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantation. J Am Coll Cardiol. 2007;50:56–60
  41. Wenaweser P, Buellesfeld L, Gerckens U, et al. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system. Catheter Cardiovasc Interv. 2007;70:760–764
  42. Astor BC, Kaczmarek RG, Hefflin B, et al. Mortality after aortic valve replacement: results from a nationally representative database. Ann Thorac Surg. 2000;70:1939–1945
  43. Shemin RJ. Percutaneous valve intervention: a surgeon's perspective. Circulation. 2006;113:774–775
  44. Casserly IP, Kapadia SR. Advances in percutaneous valvular intervention. Exp Rev Cardiovasc Ther. 2005;3:143–158
  45. Jongbloed MR, Schalij MJ, Zeppenfeld K, et al. Clinical applications of intracardiac echocardiography in interventional procedures. Heart. 2005;91:981–990
  46. Nordmeyer J, Khambadkone S, Coats L, et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation. 2007;115:1392–1397
  47. Tops LF, Krishnan SC, Schuijf JD, et al. Noncoronary applications of cardiac multi-detector row computed tomography. J Am Coll Cardiol Imaging. 2008;1:94–106
  48. Maselli D, Guarracino F, Chiaramonti F, et al. Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation. 2006;114:377–380
  49. Tops LF, Van de Veire NR, Schuijf JD, et al. Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus: implications for percutaneous mitral annuloplasty. Circulation. 2007;115:1426–1432
  50. Choure AJ, Garcia MJ, Hesse B, et al. In vivo analysis of the anatomical relationship of coronary sinus to mitral annulus and left circumflex coronary artery using cardiac multidetector computed tomography: implications for percutaneous coronary sinus mitral annuloplasty. J Am Coll Cardiol. 2006;48:1938–1945
  51. Tops LF, Wood DA, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography: Implications for transcatheter aortic valve replacement. J Am Coll Cardiol Imaging. 2008;1:321–330
  52. Naqvi TZ, Zarbatany D, Molloy MD, et al. Intracardiac echocardiography for percutaneous mitral valve repair in a swine model. J Am Soc Echocardiogr. 2006;19:147–153
  53. Silvestry FE, Rodriguez LL, Herrmann HC, et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr. 2007;20:1131–1140
  54. Gottdiener JS, Bednarz J, Devereux R, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004;17:1086–1119
  55. Foster E, Wasserman HS, Gray W, et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol. 2007;100:1577–1583

 Dr. Bax receives research grants from Edwards Lifesciences, GE Healthcare, BMS Medical Imaging, Boston Scientific, Medtronic, and St. Jude Medical. Dr. Webb is consultant to Edwards Lifesciences, Guided Delivery Systems, Mitralign, and Kardium. The remaining authors have no conflicts of interest to disclose.

PII: S0146-2806(08)00085-6

doi: 10.1016/j.cpcardiol.2008.05.002

Current Problems in Cardiology
Volume 33, Issue 8 , Pages 417-457 , August 2008

Article Tools

* Image Usage & Resolution